Nomura Holdings’s GALENA BIOPHARMA INC COM RXII Stock Holding History

Nomura Holdings’s Portfolio RXII Stock Details RXII Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-21,800	Closed	-$32K	–	2323
2015 Q4	$32K	Buy	21,800 +11,900	+120%	+$17.5K	﹤0.01%	1785
2015 Q3	$16K	Buy	+9,900	New	+$16K	﹤0.01%	1596
2015 Q1	–	Sell	-3,700	Closed	-$6K	–	2622
2014 Q4	$6K	Sell	3,700 -13,800	-79%	-$22.4K	﹤0.01%	2233
2014 Q3	$37K	Sell	17,500 -930	-5%	-$1.97K	﹤0.01%	2649
2014 Q2	$55K	Sell	18,430 -75,445	-80%	-$225K	﹤0.01%	2597
2014 Q1	$234K	Buy	93,875 +47,399	+102%	+$118K	﹤0.01%	2250
2013 Q4	$229K	Sell	46,476 -23,962	-34%	-$118K	﹤0.01%	1689
2013 Q3	$160K	Buy	70,438 +54,976	+356%	+$125K	﹤0.01%	1972
2013 Q2	$34K	Buy	+15,462	New	+$34K	﹤0.01%	2097

Other funds holding RXII

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

BIM

BlackRock Investment Management Wilmington, Delaware $86.4B AUM 16.83% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

TCIM

TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return

Nomura Holdings's RXII Position: Q1 2016 in Review

Nomura Holdings sold out of GALENA BIOPHARMA INC COM (RXII) in Q1 2016, closing a stake of 21,800 shares — an estimated $32K sold.

Nomura Holdings first reported a position in RXII in Q2 2013 and held it in 9 quarters. The position peaked at $234K in Q1 2014. 71 funds tracked by Wall St. Rank hold RXII as of Q1 2016.

Nomura Holdings reported no remaining GALENA BIOPHARMA INC COM position as of Q1 2016 after selling out during the quarter.
Nomura Holdings sold 21,800 GALENA BIOPHARMA INC COM shares in Q1 2016, an estimated $32K.
Nomura Holdings first reported a position in GALENA BIOPHARMA INC COM in Q2 2013 and held it in 9 quarters.
Nomura Holdings's GALENA BIOPHARMA INC COM position peaked at $234K in Q1 2014.
71 funds tracked by Wall St. Rank held GALENA BIOPHARMA INC COM as of Q1 2016.

Based on Nomura Holdings's 13F filing for Q1 2016, filed 16 May 2016.